The landscape of cancer immunotherapy is rapidly evolving beyond conventional checkpoint inhibition strategies, with innovative approaches emerging that promise to overcome current limitations and expand therapeutic possibilities. These next-generation developments represent a quantum leap forward in our ability to harness immune system potential for cancer treatment, addressing resistance mechanisms and enhancing therapeutic efficacy across diverse… Read.